Warren Averett Asset Management, LLC Bristol Myers Squibb CO Transaction History

Warren Averett Asset Management, LLC

$5.05 Billion
Q2 2024

A detailed history of Warren Averett Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 13,371 shares of BMY stock, worth $680,851. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,371

Previous 12,360 8.18%

Holding current value

$680,851

Previous $670,000 17.16%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $40,692 - $53,572	1,011 Added 8.18%	13,371 $555,000
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $63,141 - $71,590	1,316 Added 11.92%	12,360 $670,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $27,100 - $32,338	559 Added 5.33%	11,044 $566,000
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $62,405 - $69,778	1,078 Added 11.46%	10,485 $608,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $624,740 - $693,676	-9,806 Reduced 51.04%	9,407 $601,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $80,757 - $91,597	-1,229 Reduced 6.01%	19,213 $1.33 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $729,380 - $863,689	10,651 Added 108.78%	20,442 $1.47 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $692 - $409,403	5,328 Added 119.38%	9,791 $696,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $8,859 - $9,757	-122 Reduced 2.66%	4,463 $343,000
Q1 2022 May 17, 2022	SELL	$61.48 - $73.72 $47,647 - $57,133	-775 Reduced 14.46%	4,585 $335,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $41,563 - $48,453	775 Added 16.9%	5,360 $358,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $3,254 - $3,812	55 Added 1.21%	4,585 $272,000
Q2 2021 Aug 17, 2021	BUY	$61.91 - $67.42 $16,282 - $17,731	263 Added 6.16%	4,530 $306,000
Q1 2021 May 24, 2021	BUY	$59.34 - $66.74 $37,918 - $42,646	639 Added 17.61%	4,267 $286,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $209,480 - $237,380	3,628 New	3,628 $218,000
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $183,488 - $203,329	-3,195 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$54.82 - $64.09 $175,149 - $204,767	3,195 New	3,195 $202,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $145,139 - $210,921	-3,128 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $153,928 - $200,786	3,128 New	3,128 $210,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $559,764 - $725,880	-11,480 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$55.19 - $62.25 $331 - $373	6 Added 0.05%	11,480 $713,000
Q2 2018 Aug 02, 2018	BUY	$50.53 - $62.98 $353 - $440	7 Added 0.06%	11,474 $635,000
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $373,661 - $430,159	-6,236 Reduced 35.23%	11,467 $725,000
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $65,274 - $71,166	1,089 Added 6.55%	17,703 $1.09 Million
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $917,591 - $1.06 Million	16,614	16,614 $1.06 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Warren Averett Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warren Averett Asset Management, LLC with notifications on news.

Account

Warren Averett Asset Management, LLC Bristol Myers Squibb CO Transaction History